Members' area

Scientific programme

Full Programme

15:50
Auditorium 2
Session starts at 15:05

OC1.4

5β-reductase (AKR1D1) is downregulated in patients with non-alcoholic fatty liver disease and protects against hepatocellular carcinoma cell proliferation in vitro.

Nikolaos Nikolaou (University of Oxford, United Kingdom)

P171

5β-reductase (AKR1D1) isoforms differentially regulate natural and synthetic glucocorticoid clearance and glucocorticoid receptor activation in vitro.

Nathan Appanna, Anastasia Arvaniti, Elena Gangitano, Karen Morris, Sherly George, Brian Keevil, Jeremy Tomlinson, Nikolaos Nikolaou

P186

AKR1D1 (5β-reductase) deletion drives hepatic inflammation, fibrosis and tumour development in vivo.

Shelley Harris, Nikolaos Nikolaou, Anastasia Arvaniti, Roger Cox, Laura Gathercole, Jeremy Tomlinson

SfE BES 2019

SfE BES 2019 Scientific programme Abstracts Programme Committee

Join or renew

Be part of our global endocrine community. Join or renew your membership online to stay at the forefront of the field and enjoy access to grants, prizes, awards, Society journals and more.

Find out more